(Q44651731)

5 December 2017

title

Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation (English)

1 reference

recombinant fusion proteins

5 December 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2003.08.005

31 March 2024

author name string

F. Balbontin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

B. Kiberd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

D. Singh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

J. Squires

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

A. Fraser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

P. Belitsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

J. Lawen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611972

31 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0041134503008686?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2003.08.005

https://api.elsevier.com/content/article/PII:S0041134503008686?httpAccept=text/plain

31 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2003.08.005

Transplantation Proceedings

31 March 2024

published in

1 reference

5 December 2017

volume

35

1 reference

5 December 2017

issue

7

1 reference

5 December 2017

page(s)

2409-2411

1 reference

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

The Banff 97 working classification of renal allograft pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

inferred from DOI database lookup

7 January 2021

based on heuristic

The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2003.08.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

1 reference

5 December 2017

1 reference